TriClip CED RWE Study

NCT06920745 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2200

Last updated 2025-08-11

No results posted yet for this study

Summary

This Coverage with Evidence Development (CED) study evaluates the long-term health outcomes of patients with symptomatic, severe or greater Tricuspid Regurgitation who received a Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER) procedure using the TriClip system.

Conditions

  • Tricuspid Regurgitation

Interventions

DEVICE

The TriClip System

The TriClip System

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-08
Primary Completion
2032-07-31
Completion
2032-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06920745 on ClinicalTrials.gov